TSS
ACHN

Two Sigma Securities’s Achillion Pharmaceuticals ACHN Stock Holding History

Two Sigma Securities’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-13,773
Closed -$50K – 2774
2019
Q3 		$50K Buy
13,773
+2,029
+17% +$7.82K ﹤0.01% 1973
2019
Q2 		$31K Buy
+11,744
New +$34.7K ﹤0.01% 1918
2017
Q3 		– Sell
-15,805
Closed -$73K – 1328
2017
Q2 		$73K Buy
+15,805
New +$63.5K 0.01% 685

Other funds holding ACHN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Securities's ACHN Position: Q4 2019 in Review

Two Sigma Securities sold out of Achillion Pharmaceuticals (ACHN) in Q4 2019, closing a stake of 13,773 shares — an estimated $50K sold.

Two Sigma Securities first reported a position in ACHN in Q2 2017 and held it in 3 quarters. The position peaked at $73K in Q2 2017. 132 funds tracked by Wall St. Rank hold ACHN as of Q4 2019.

  • Two Sigma Securities reported no remaining Achillion Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Two Sigma Securities sold 13,773 Achillion Pharmaceuticals shares in Q4 2019, an estimated $50K.
  • Two Sigma Securities first reported a position in Achillion Pharmaceuticals in Q2 2017 and held it in 3 quarters.
  • Two Sigma Securities's Achillion Pharmaceuticals position peaked at $73K in Q2 2017.
  • 132 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2019.

Based on Two Sigma Securities's 13F filing for Q4 2019, filed 14 Feb 2020.